Skip to main content
Top
Published in: BMC Public Health 1/2016

Open Access 01-12-2015 | Research article

Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP)

Authors: Carolina J. Klett-Tammen, Gérard Krause, Linda Seefeld, Jördis J. Ott

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

Severity and incidence of vaccine-preventable infections with influenza viruses, s. pneumoniae and c. tetani increase with age. Furthermore, vaccine coverage in the elderly is often insufficient. The aim of this study is to identify socio-economic and knowledge-, attitude- and practice- (KAP)-related determinants of vaccination against influenza, pneumococcal disease and tetanus in the older German population.

Methods

We analysed data from a German nationally representative questionnaire-based KAP-survey on infection prevention and hygiene behavior in the elderly (n = 1223). We used logistic regressions to assess impacts of socio-demographic- and KAP-related variables on vaccine uptake in general and on tetanus-, influenza- and pneumococcal vaccination. To generate KAP-scores, we applied factor analyses and analysed scores as predictors of specific vaccinations.

Results

A low rated personal health status was associated with a higher uptake of influenza vaccine whereas place of residence within Germany strongly impacted on pneumococcal vaccination. For tetanus and influenza vaccination, the strongest single vaccination predictor was attitude-related, i.e., the perceived importance of the vaccine (OR = 18.1, 95 % CI = 4.5–71.8; OR = 23.0, 95 % CI = 14.9–35.3, respectively). Pneumococcal vaccination was mostly knowledge-associated, i.e., knowing the recommendation predicted uptake (OR = 17.1, 95 % CI = 9.5–30.7). Regarding the generated KAP-scores, the practice-score reflecting vaccine related behavior such as having a vaccination record, was predictive for all vaccines considered. The knowledge-score was associated with influenza (OR = 1.3, 95 % CI = 1.0–1.6) and pneumococcal vaccination (OR = 1.2, 95 % CI = 1.0–1.5). Uniquely for influenza vaccination, the attitude-score was linked to vaccine uptake (OR = 1.1, 95 % CI = 1.0–1.1).

Conclusions

Our results indicate that predictors of vaccination uptake in the elderly strongly depend on vaccine type and that scores of KAP are useful and valid to condense information from numerous individual KAP-variables. While awareness for vaccinations against influenza and tetanus is fairly high already it might have to be increased for vaccinations against pneumocoocal infections.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis. 2000;182:840–7.CrossRefPubMed Kalin M, Ortqvist A, Almela M, Aufwerber E, Dwyer R, Henriques B, et al. Prospective study of prognostic factors in community-acquired bacteremic pneumococcal disease in 5 countries. J Infect Dis. 2000;182:840–7.CrossRefPubMed
2.
go back to reference CDC. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep. 2010;59(RR08):1–62. CDC. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP). Morb Mortal Wkly Rep. 2010;59(RR08):1–62.
3.
go back to reference ECDC. Annual epidemiological report 2014 - vaccine-preventable diseases. Stockholm: ECDC; 2014. ECDC. Annual epidemiological report 2014 - vaccine-preventable diseases. Stockholm: ECDC; 2014.
4.
go back to reference Payeras A, Villoslada A, Garau M, Salvador MN, Gallegos MC: Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine. Int J Infect Dis. 2015;33:22-7. doi:10.1016/j.ijid.2014.12.035. Epub 2014 Dec 23. Payeras A, Villoslada A, Garau M, Salvador MN, Gallegos MC: Evolution of pneumococcal infections in adult patients during a four-year period after vaccination of a pediatric population with 13-valent pneumococcal conjugate vaccine. Int J Infect Dis. 2015;33:22-7. doi:10.​1016/​j.​ijid.​2014.​12.​035. Epub 2014 Dec 23.
5.
go back to reference Riquelme R, Torres A, El-Ebiary M, Bellacasa JP, Estruch R, Mensa J, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med. 1996;154(5):1450–5.CrossRefPubMed Riquelme R, Torres A, El-Ebiary M, Bellacasa JP, Estruch R, Mensa J, et al. Community-acquired pneumonia in the elderly: a multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med. 1996;154(5):1450–5.CrossRefPubMed
6.
go back to reference Hsu H, Shutt K, Moore M, Beall B, Bennett N, Craig A, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244–56.PubMedCentralCrossRefPubMed Hsu H, Shutt K, Moore M, Beall B, Bennett N, Craig A, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244–56.PubMedCentralCrossRefPubMed
8.
go back to reference Act on the Reform of the Communicable Diseases Law (Communicable Diseases Law Reform Act). Act on the Reform of the Communicable Diseases Law (Communicable Diseases Law Reform Act).
9.
go back to reference Fätkenheuer G, Kwetkat A, Pletz MW, Schelling J, Schulz RJ, van der Linden M, et al. Prevention in the elderly: position paper on pneumococcal vaccinations. Results of an expert workshop on 15 November 2013 in Cologne, Germany. Z Gerontol Geriatr. 2014;47(4):302-9. doi:10.1007/s00391-014-0650-9. [Article in German]. Fätkenheuer G, Kwetkat A, Pletz MW, Schelling J, Schulz RJ, van der Linden M, et al. Prevention in the elderly: position paper on pneumococcal vaccinations. Results of an expert workshop on 15 November 2013 in Cologne, Germany. Z Gerontol Geriatr. 2014;47(4):302-9. doi:10.​1007/​s00391-014-0650-9. [Article in German].
10.
go back to reference Robert-Koch-Institut. Official vaccine reccomendations of the german standing committee on vaccination as of august 2014. Epidemiologisches Bulletin. 2014;34:305–40. Robert-Koch-Institut. Official vaccine reccomendations of the german standing committee on vaccination as of august 2014. Epidemiologisches Bulletin. 2014;34:305–40.
11.
go back to reference Poethko-Muller C, Schmitz R. [Vaccination coverage in german adults: results of the german health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):845–57.CrossRefPubMed Poethko-Muller C, Schmitz R. [Vaccination coverage in german adults: results of the german health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):845–57.CrossRefPubMed
13.
go back to reference Rosenstock I. The health belief model and preventive health behaviour. Health Educ Behav. 1974;2:354–86.CrossRef Rosenstock I. The health belief model and preventive health behaviour. Health Educ Behav. 1974;2:354–86.CrossRef
14.
go back to reference Lau DT, Kirby JB. The relationship between living arrangement and preventive care use among community-dwelling elderly persons. Am J Public Health. 2009;99(7):1315–21.PubMedCentralCrossRefPubMed Lau DT, Kirby JB. The relationship between living arrangement and preventive care use among community-dwelling elderly persons. Am J Public Health. 2009;99(7):1315–21.PubMedCentralCrossRefPubMed
15.
go back to reference Bohmer MM, Walter D, Krause G, Muters S, Gosswald A, Wichmann O. Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin. 2011;7(12):1317–25.CrossRefPubMed Bohmer MM, Walter D, Krause G, Muters S, Gosswald A, Wichmann O. Determinants of tetanus and seasonal influenza vaccine uptake in adults living in Germany. Hum Vaccin. 2011;7(12):1317–25.CrossRefPubMed
16.
go back to reference Mieczkowski TA, SAW. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine. 2002;20:1383–92.CrossRefPubMed Mieczkowski TA, SAW. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine. 2002;20:1383–92.CrossRefPubMed
17.
go back to reference Böhmer MM, Walter D, Falkenhorst G, Müters S, Krause G, Wichmann O. Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health. 2012;12:938.PubMedCentralCrossRefPubMed Böhmer MM, Walter D, Falkenhorst G, Müters S, Krause G, Wichmann O. Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany. BMC Public Health. 2012;12:938.PubMedCentralCrossRefPubMed
18.
go back to reference Terry MA, Wilson SA, Bardella IJ, Ilene Katz J, Zimmermann RK, Santibanez MPN, et al. Knowledge and beliefs about inlfuenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc. 2002;50:1711–6.CrossRefPubMed Terry MA, Wilson SA, Bardella IJ, Ilene Katz J, Zimmermann RK, Santibanez MPN, et al. Knowledge and beliefs about inlfuenza, pneumococcal disease, and immunizations among older people. J Am Geriatr Soc. 2002;50:1711–6.CrossRefPubMed
19.
go back to reference Nowalk MP, Zimmerman RK, Tabbarah M, Raymund M, Jewell IK. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam Pract. 2006;7:2.PubMedCentralCrossRefPubMed Nowalk MP, Zimmerman RK, Tabbarah M, Raymund M, Jewell IK. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam Pract. 2006;7:2.PubMedCentralCrossRefPubMed
22.
go back to reference Kleinbaum D, Klein M. Logistic Regression. New York: Springer; 2010. Kleinbaum D, Klein M. Logistic Regression. New York: Springer; 2010.
23.
go back to reference Rothman K. Epidemiology. An Introduction. New York: Oxford University Press; 2002. Rothman K. Epidemiology. An Introduction. New York: Oxford University Press; 2002.
24.
go back to reference Bartlett JE, Kotrlik JW, Higgins CC. Organizational Research: determing appropriate sample size in survey research. Inf Technol Learn Perform J. 2001;19(1):43–50. Bartlett JE, Kotrlik JW, Higgins CC. Organizational Research: determing appropriate sample size in survey research. Inf Technol Learn Perform J. 2001;19(1):43–50.
25.
go back to reference Streefland P, Chowdhury AMR, Ramos-Jimenez P. Patterns of vaccination acceptance. Soc Sci Med. 1999;49:1705–16.CrossRefPubMed Streefland P, Chowdhury AMR, Ramos-Jimenez P. Patterns of vaccination acceptance. Soc Sci Med. 1999;49:1705–16.CrossRefPubMed
26.
go back to reference Gargano LM, Underwood NL, Sales JM, Seib K, Morfaw C, Murray D, et al. Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt. Hum Vacc Immunotherapeutics. 2015;1(7):1641–7.CrossRef Gargano LM, Underwood NL, Sales JM, Seib K, Morfaw C, Murray D, et al. Influence of sources of information about influenza vaccine on parental attitudes and adolescent vaccine receipt. Hum Vacc Immunotherapeutics. 2015;1(7):1641–7.CrossRef
27.
go back to reference Sridhar S, Belhouchat K, Drali T, Benkouiten S, Parola P, Brouqui P, et al. French Hajj pilgrims’ experience with pneumococcal infection and vaccination: a knowledge, attitudes and practice (KAP) evaluation. Travel Med Infect Dis. 2015;13(3):251–5.CrossRefPubMed Sridhar S, Belhouchat K, Drali T, Benkouiten S, Parola P, Brouqui P, et al. French Hajj pilgrims’ experience with pneumococcal infection and vaccination: a knowledge, attitudes and practice (KAP) evaluation. Travel Med Infect Dis. 2015;13(3):251–5.CrossRefPubMed
28.
go back to reference Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health. 2014;14:442.PubMedCentralCrossRefPubMed Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health. 2014;14:442.PubMedCentralCrossRefPubMed
29.
go back to reference Johnson D, Nichol K, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7 Suppl 2):S28–35.CrossRefPubMed Johnson D, Nichol K, Lipczynski K. Barriers to adult immunization. Am J Med. 2008;121(7 Suppl 2):S28–35.CrossRefPubMed
30.
go back to reference Kyaw M, Nguyen-Van-Tam J, Pearson J. Family doctor advice is the main determinant of pneumococcal vaccine uptake. J Epidemiol Community Health. 1999;53:589–90.PubMedCentralCrossRefPubMed Kyaw M, Nguyen-Van-Tam J, Pearson J. Family doctor advice is the main determinant of pneumococcal vaccine uptake. J Epidemiol Community Health. 1999;53:589–90.PubMedCentralCrossRefPubMed
31.
go back to reference McRee A, Brewer N, Reiter P, Gottlieb S, Smith J. The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): Scale Development and Associations With Intentions to Vaccinate. Sexually Transmitted Diseases. 2010;37(4):234-9. doi:10.1097/OLQ.0b013e3181c37e15. McRee A, Brewer N, Reiter P, Gottlieb S, Smith J. The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): Scale Development and Associations With Intentions to Vaccinate. Sexually Transmitted Diseases. 2010;37(4):234-9. doi:10.​1097/​OLQ.​0b013e3181c37e15​.
32.
go back to reference Lasser KE, Kelly B, Maier J, Murillo J, Hoover S, Isenberg K, et al. Discussions about preventive services: a qualitative study. BMC Fam Pract. 2008;9:49.PubMedCentralCrossRefPubMed Lasser KE, Kelly B, Maier J, Murillo J, Hoover S, Isenberg K, et al. Discussions about preventive services: a qualitative study. BMC Fam Pract. 2008;9:49.PubMedCentralCrossRefPubMed
33.
go back to reference Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062–7.CrossRefPubMed Fleming DM, Andrews NJ, Ellis JS, Bermingham A, Sebastianpillai P, Elliot AJ, et al. Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health. 2010;64(12):1062–7.CrossRefPubMed
34.
go back to reference WHO. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec. 2005;80(33):279–87. WHO. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec. 2005;80(33):279–87.
35.
go back to reference Fedson DS. Preventing non bacteremic pneumococcal pneumonia in older adults. Hum Vacc Immunotherapeutics. 2014;10(5):1322–30.CrossRef Fedson DS. Preventing non bacteremic pneumococcal pneumonia in older adults. Hum Vacc Immunotherapeutics. 2014;10(5):1322–30.CrossRef
36.
go back to reference Gutiérrez-Rodríguez M, Lasheras-Carbajo M, Taveira-Jiménez J, Ordobás-Gavín M, Martín-Martínez F, García-Comas L, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008–2011. Eurosurveillance. 2014;19(40):20922.CrossRefPubMed Gutiérrez-Rodríguez M, Lasheras-Carbajo M, Taveira-Jiménez J, Ordobás-Gavín M, Martín-Martínez F, García-Comas L, et al. Effectiveness of 23-valent pneumococcal polysaccharide vaccine in adults aged 60 years and over in the Region of Madrid, Spain, 2008–2011. Eurosurveillance. 2014;19(40):20922.CrossRefPubMed
37.
go back to reference WHO. Tetanus vaccine. WHO position paper. Wkly Epidemiol Rec. 2006;81(20):198–208. WHO. Tetanus vaccine. WHO position paper. Wkly Epidemiol Rec. 2006;81(20):198–208.
38.
go back to reference Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: A comparison of meta-analyses. Eur J Epidemiol. 2004;19:353–63.CrossRefPubMed Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: A comparison of meta-analyses. Eur J Epidemiol. 2004;19:353–63.CrossRefPubMed
Metadata
Title
Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP)
Authors
Carolina J. Klett-Tammen
Gérard Krause
Linda Seefeld
Jördis J. Ott
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-2784-8

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue